Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical
KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling
Globe Newswire21-02-2023, 13:07
CGTN: Flying Tigers' legacy celebrated to nourish a lasting China-U.S. bond 29-08-2025, 10:14